Search results
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 2 days agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Lululemon Athletica Was Among The Worst-Performing Stocks Last Week (May 19-May 26, 2024): Are These...
Benzinga· 2 hours ago10 worst-performing large-cap stocks last week. National Grid, James Hardie, KE Holdings, JD.Com,...
Equity Shot: Airbnb's IPO is finally here
TechCrunch· 6 hours agoHello and welcome back to Equity, TechCrunch’s venture capital-focused podcast where we unpack the numbers behind the headlines. Today we have an Equity...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 3 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 6 hours agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
AOL· 2 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator told vaccine makers last month to update their vaccines ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 3 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Dow Jones Dips As AI Stock Microsoft Shines; Nvidia Rallies On These Bullish Calls
Investor's Business Daily· 6 days agoTechnology was a top performer in the composite, rallying 3% after Morgan Stanley upgraded the stock...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 3 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
